Feedback / Questions
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
https://www.globenewswire.com/news-release/2023/03/06/2621520/33333/en/Coherus-BioSciences-Reports-Fourth-Quarter-and-Full-Year-2022-Results.html
Mar 6, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next